Publications











Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group.
J Clin Oncol 2016 Jun 25;34(16):1935-44. Epub 2016 Jan 25.
Ashish M. Kamat, University of Texas MD Anderson Cancer Center, Houston, TX; Richard J. Sylvester, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Andreas Böhle, HELIOS Agnes Karll Hospital, Bad Schwartau, Germany; Joan Palou, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Donald L. Lamm, University of Arizona and BCG Oncology, Phoenix, AZ; Maurizio Brausi, Azienda Unità Sanitaria Locale di Modena, Modena, Italy; Mark Soloway, University of Miami School of Medicine, Miami, FL; Raj Persad, Bristol Royal Infirmary and Bristol Urological Institute, Bristol, United Kingdom; Roger Buckley, North York General Hospital, Toronto, Ontario, Canada; Marc Colombel, Claude Bernard University, Hôpital Edouard Herriot, Lyon, France; and J. Alfred Witjes, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation.
World J Urol 2016 Feb 30;34(2):173-80. Epub 2015 May 30.
Department of Urology, Radboud University Medical Centre, Geert Grooteplein Zuid 10 (659), P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
Eur J Cancer 2016 Feb 4;54:131-8. Epub 2016 Jan 4.
Department and Laboratory of Urology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Spain. Electronic address:

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Eur Urol 2015 Nov 16;68(5):868-79. Epub 2015 Jul 16.
Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; Department of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.




ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer.
J Urol 2015 Apr 28;193(4):1144-50. Epub 2014 Oct 28.
Department of Pathology, Columbia University, New York, New York; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Eur Urol 2015 Mar 2;67(3):402-22. Epub 2015 Jan 2.
Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy.




European guidelines on upper tract urothelial carcinomas: 2013 update.
Eur Urol 2013 Jun 19;63(6):1059-71. Epub 2013 Mar 19.
Department of Urology, Groupe Hospitalier Pitié - Salpêtrière, Assistance Publique Hopitaux de Paris, Faculty of Medicine Pierre et Marie Curie, Institut Universitaire de Cancérologie GRC5, University Paris 6, Paris, France.










OF